ClinicalTrials.Veeva

Menu

RDW to Platlet Count Ratio in CKD Patients

S

Sohag University

Status

Not yet enrolling

Conditions

Cardiovascular Complication

Treatments

Diagnostic Test: RDW to platlet count ratio

Study type

Observational

Funder types

Other

Identifiers

NCT05754827
CKD and CV complications

Details and patient eligibility

About

The aim of the study is to determine Red blood cell distribution width to platelet count ratio as a predictor of cardiovascular complications in CKD patients

Full description

comparative study between RDW to Platlet count ratio in CKD patients without cardiovascular complications and CKD patients with cardiovascular complications

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  • Inclusion Criteria:

    • CKD Patients and patients receive dialysis >18 years old
  • Exclusion Criteria:

    • Serious complications of any other organs
    • patients who had previously undergone kidney transplantation .
    • CKD patients with history of previous CVD
    • patients with an infection, blood transfusion or receiving immunosuppressive drugs, as this may have affected the inflammatory response within the 3 months
    • patients who were pregnant
    • patients with chronic hematological disease
    • patient<18 years

Trial design

100 participants in 2 patient groups

1-CKD patients without cardiovascular complications
Treatment:
Diagnostic Test: RDW to platlet count ratio
2-CKD patients with cardiovascular complications
Treatment:
Diagnostic Test: RDW to platlet count ratio

Trial contacts and locations

0

Loading...

Central trial contact

Doha A Mohamed; Ali M Kassem

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems